Russell Investments Group
VRCA icon

Russell Investments Group’s Verrica Pharmaceuticals VRCA Stock Holding History

Russell Investments Group’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-193
Closed -$2.8K – 3802
2024
Q3 		$2.8K Buy
193
+131
+211% +$5.9K ﹤0.01% 3320
2024
Q2 		$4.52K Buy
62
+55
+786% +$4.22K ﹤0.01% 3234
2024
Q1 		$420 Hold
7
– – ﹤0.01% 3227
2023
Q4 		$520 Buy
+7
New +$288 ﹤0.01% 3122

Other funds holding VRCA

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SA
Sovran Advisors San Diego, California $1.27B AUM 18.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Russell Investments Group's VRCA Position: Q4 2024 in Review

Russell Investments Group sold out of Verrica Pharmaceuticals (VRCA) in Q4 2024, closing a stake of 193 shares — an estimated $2.8K sold.

Russell Investments Group first reported a position in VRCA in Q4 2023 and held it in 4 quarters. The position peaked at $4.52K in Q2 2024. 81 funds tracked by Wall St. Rank hold VRCA as of Q4 2024.

  • Russell Investments Group reported no remaining Verrica Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Russell Investments Group sold 193 Verrica Pharmaceuticals shares in Q4 2024, an estimated $2.8K.
  • Russell Investments Group first reported a position in Verrica Pharmaceuticals in Q4 2023 and held it in 4 quarters.
  • Russell Investments Group's Verrica Pharmaceuticals position peaked at $4.52K in Q2 2024.
  • 81 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q4 2024.

Based on Russell Investments Group's 13F filing for Q4 2024, filed 13 Feb 2025.